Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 7/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9254072 | 0.83 | TRPA1 (0.49) | AHRTRPA1ALDH1A1TSHRTDP1 | |
| SCHEMBL9262835 | 0.79 | PTGS2 (0.54) | TRPA1 | |
| SCHEMBL27759221 | 0.77 | CYP2A6 (0.54) | TRPA1ALDH1A1TSHRTDP1CYP2A6 | |
| SCHEMBL9263223 | 0.77 | HSD11B1 (0.41) | TRPA1ALDH1A1TSHRTDP1CA2 | |
| SCHEMBL23746850 | 0.76 | TRPA1 (0.45) | TRPA1ALDH1A1TSHRTDP1CA2 | |
| SCHEMBL12597777 | 0.76 | PTGS2 (0.47) | TRPA1ALDH1A1TSHRTDP1CYP2A6 | |
| SCHEMBL9258898 | 0.76 | TRPA1 (0.45) | TRPA1TSHRPTPN5PDK2 | |
| SCHEMBL9261398 | 0.75 | CYP2A6 (0.44) | TRPA1ALDH1A1TSHRTDP1CYP2A6 | |
| SCHEMBL9258465 | 0.75 | HSD11B1 (0.40) | TRPA1ALDH1A1TSHRTDP1PTPN5 | |
| SCHEMBL29833702 | 0.74 | ALDH1A1 (0.46) | TRPA1ALDH1A1TSHRTDP1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10544092-B2 | Malononitrile oxime ether compound and use thereof | SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD. (CN) | 2020-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10544092-B2 | Malononitrile oxime ether compound and use thereof | ME1, MAL2, ME3 | AHR 1018/4885TRPA1 2997/4885ALDH1A1 791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.